T0	Chemical 145 147	Cr
T1	Disease 168 183	Alport syndrome
#2	AnnotatorNotes T1	DOID:10983
T10	Chemical 886 888	Cr
T11	Disease 1007 1010	CKD
T13	Chemical 1043 1045	Cr
T15	Chemical 1132 1134	Cr
T18	Chemical 1395 1397	Cr
T19	Disease 1442 1453	proteinuria
#8	AnnotatorNotes T19	DOID:576
T2	Disease 275 278	CKD
#9	AnnotatorNotes T2	DOID:784
T21	Chemical 1467 1469	Cr
T22	Disease 1507 1518	proteinuria
T24	Chemical 1624 1626	Cr
T4	Chemical 435 437	Cr
T5	Chemical 551 553	Cr
T6	Chemical 703 705	Cr
T8	Disease 829 845	higher CKD stage
#18	AnnotatorNotes T8	DOID:784
T7	Disease 1678 1726	CKD progression in patients with Alport syndrome
#1	AnnotatorNotes T7	DOID:784,DOID:10983
T9	Biomarker 1619 1626	uEGF/Cr
R2	Association Arg1:T9 Arg2:T7	
T12	Biomarker 881 888	uEGF/Cr
T14	Gene-Protein 140 144	uEGF
T16	Gene-Protein 546 550	uEGF
T17	Gene-Protein 430 434	uEGF
T20	Gene-Protein 698 702	uEGF
T23	Gene-Protein 1038 1042	uEGF
T25	Gene-Protein 1127 1131	uEGF
T26	Gene-Protein 1390 1394	uEGF
T27	Gene-Protein 1462 1466	uEGF
T28	Gene-Protein 1619 1623	uEGF
T29	Gene-Protein 881 885	uEGF
T30	Biomarker 140 147	uEGF/Cr
T31	Biomarker 1462 1469	uEGF/Cr
T32	Biomarker 1390 1397	uEGF/Cr
T33	Biomarker 1121 1134	Lower uEGF/Cr
T34	Biomarker 698 705	uEGF/Cr
T35	Biomarker 430 437	uEGF/Cr
#3	AnnotatorNotes T14	not found
T36	Biomarker 546 555	uEGF/Crâ€™s
